# Acetazolamide or Metolazone in Acute Heart Failure

> **NCT06273397** · NA · NOT_YET_RECRUITING · sponsor: **Clinica Alemana de Santiago** · enrollment: 1050 (estimated)

## Conditions studied

- Heart Failure Acute
- Decompensated Heart Failure

## Interventions

- **DRUG:** Acetazolamide 250 MG
- **DRUG:** Metolazone 2.5 MG
- **DRUG:** Furosemide Injection

## Key facts

- **NCT ID:** NCT06273397
- **Lead sponsor:** Clinica Alemana de Santiago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 1050 (ESTIMATED)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273397, "Acetazolamide or Metolazone in Acute Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06273397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*